| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8679357 | Thrombosis Research | 2018 | 30 Pages |
Abstract
HBV infection is an independent risk factor of CLR, in addition to CYP2C19 gene mutations. (Pharmacogenetic and Pharmacokinetic Study of Clopidogrel; NCT01968499).
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Lianghong Ying, Fei Wang, Jing Zhang, Lu Yang, Xiaoxuan Gong, Yuansheng Fan, Ke Xu, Juan Li, Yi Lu, Lianlian Mei, Zihao Zhou, Chunjian Li,